Government & Policy

"Our experience is that people will report if there are issues with their product," said ONC Chief Donald Rucker.

Despite deregulation, we won't let EHR makers run wild, ONC chief promises

By Mike Miliard 01:08 pm September 22, 2017

New criteria for vendors are meant to ease burdens and ultimately pass cost-savings down to the hospitals and systems that buy electronic health record software, Donald Rucker says.

ONC dials back meaningful use certification program

By Tom Sullivan 11:19 am September 21, 2017

Two big changes: EHR makers are now able to self-declare compliance with specific criteria and ONC will not audit certification bodies’ random surveillance practices.

CMS Administrator Seema Verma. Photo via Twitter

CMS says it will change direction of CMMI, wants providers to have greater flexibility in payment model design

By Susan Morse 11:44 am September 20, 2017

CMS innovation center programs in limbo as officials say free market approach will encourage competition among healthcare providers.

HHS to face audit of its own cybersecurity, incident response capabilities

By Jessica Davis 01:51 pm September 19, 2017

The increase in threats and sophistication have prompted the need to shore up government security policies, according to the agency’s updated 2017 work plan.

The Texas Army National Guard moves through flooded Houston streets from Hurricane Harvey. U.S. Army photo

Hurricanes Harvey and Irma spotlight value of telehealth as new House bill gains ground

By Mike Miliard 02:19 pm September 18, 2017

Thousands of people in Florida and Texas have made use of remote consults offered by Nemours and others.

St Jude Medical cardiac rhythm management product, pacemaker

The FDA getting involved in ordering a recall marks a major change in direction for the agency and medical device manufacturers.

Analysis: What's in an FDA recall?

By Richard Staynings 11:50 am September 15, 2017

Last week the US Food and Drug Administration (FDA) took the unprecedented step of recalling a biomedical device because of concerns over its lack of cybersecurity.

Acting FBI Director Andrew McCabe, CIA Director Mike Pompeo, Director of National Intelligence Dan Coats, NSA Director Admiral Michael Rogers, Defense Intelligence Agency Director Lt. General Vincent Stewart and Director of the National Geospatial-Intelligence Agency Robert Cardillo testify before the U.S. Senate Select Committee on Intelligence on May 11.

Citing ties to Russia, DHS bans Kaspersky products for government use

By Jessica Davis 10:29 am September 14, 2017

While Kaspersky has continuously denied any wrongdoing, the Department of Homeland Security is giving agencies just 90 days to remove all software from systems.